Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Thymus Transplantation in Complete DiGeorge Anomaly, IND#9836

NCT01220531 is registered in ClinicalTrials.gov with Sumitomo Pharma Switzerland GmbH as lead sponsor.

NCT NCT01220531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Thymus Transplantation in Complete DiGeorge Anomaly, IND#9836
Lead sponsor
Sumitomo Pharma Switzerland GmbH
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2010
Completion date
August 31, 2023
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complete digeorge anomaly, complete digeorge syndrome, digeorge anomaly, digeorge syndrome